Hu Lin-Hui, Pu Lian-Fang, Yang Dong-Dong, Zhang Cui, Wang Hui-Ping, Ding Yang-Yang, Li Man-Man, Zhai Zhi-Min, Xiong Shudao
Hematological Lab, Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China.
Oncol Lett. 2017 Nov;14(5):5619-5623. doi: 10.3892/ol.2017.6847. Epub 2017 Aug 28.
The Philadelphia (Ph; BCR-ABL) chromosome originates from a translocation event between chromosomes 9 and 22, and results in the BCR-ABL fusion gene. In chronic myelogenous leukemia (CML), the BCR-ABL gene is mainly coded for by a major breakpoint cluster region (M-bcr, e13a2 and e14a2). However, in some patients, BCR-ABL genes are encoded by a minor (m)-bcr, e1a2, and a micro (µ)-bcr region, e19a2. These transcripts revealed a different clinical course. The present study described a CML patient whose cytogenetics and FISH analyses of bone marrow revealed a karyotype of 46, XY t(9,22) (q34;q11), while the commercial kits of quantitative PCR (qPCR) failed to detect the BCR-ABL fusion gene. Further multiplex Reverse transcription-PCR (RT-PCR) and sequencing analyses identified a rare e14a3 (b3a3) fusion transcript.
费城(Ph;BCR-ABL)染色体起源于9号和22号染色体之间的易位事件,导致BCR-ABL融合基因的产生。在慢性髓性白血病(CML)中,BCR-ABL基因主要由主要断裂点簇区域(M-bcr,e13a2和e14a2)编码。然而,在一些患者中,BCR-ABL基因由次要(m)-bcr、e1a2和微小(µ)-bcr区域e19a2编码。这些转录本显示出不同的临床病程。本研究描述了一名CML患者,其骨髓的细胞遗传学和荧光原位杂交(FISH)分析显示核型为46,XY,t(9;22)(q34;q11),而定量聚合酶链反应(qPCR)的商业试剂盒未能检测到BCR-ABL融合基因。进一步的多重逆转录聚合酶链反应(RT-PCR)和测序分析鉴定出一种罕见的e14a3(b3a3)融合转录本。